ArticleClinical kidney journal2024

Tofacitinib for the treatment of refractory immune checkpoint inhibitor-associated immune nephritis.

Kiran Shivaraj et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.